# OnCo record turrisi-intergroup-0096 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/turrisi-intergroup-0096/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "turrisi-intergroup-0096" ;
  schema:name "Intergroup 0096 (Turrisi): twice-daily versus once-daily thoracic radiotherapy"@en ;
  schema:alternateName "INT 0096"@en, "Turrisi trial"@en ;
  schema:description "Showed that giving the same dose of radiotherapy twice a day for three weeks, rather than once a day for five, raises the five-year survival of limited-stage small-cell lung cancer from 16 to 26 percent."@en ;
  schema:url <https://onco.cc/trials/turrisi-intergroup-0096/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJM199901283400403> ;
  onco:status "positive" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/limited-stage-sclc/> ;
  onco:technologies <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/technologies/hypofractionated-radiotherapy/>, <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/platinum/> ;
  onco:drugs <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/etoposide/>, <https://onco.cc/drugs/platinum-etoposide/> ;
  onco:terms <https://onco.cc/terms/chemoradiation/>, <https://onco.cc/terms/curative-intent/> ;
  onco:trials <https://onco.cc/trials/convert/>, <https://onco.cc/trials/adriatic/> .